Intellia Therapeutics (NTLA) Treasury Shares (2016 - 2025)
Historic Treasury Shares for Intellia Therapeutics (NTLA) over the last 11 years, with Q3 2025 value amounting to $5.2 million.
- Intellia Therapeutics' Treasury Shares fell 379.49% to $5.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.2 million, marking a year-over-year decrease of 379.49%. This contributed to the annual value of $5.5 million for FY2024, which is 3725.55% up from last year.
- Per Intellia Therapeutics' latest filing, its Treasury Shares stood at $5.2 million for Q3 2025, which was down 379.49% from $5.3 million recorded in Q2 2025.
- Intellia Therapeutics' 5-year Treasury Shares high stood at $5.7 million for Q1 2024, and its period low was $442740.0 during Q1 2021.
- Moreover, its 5-year median value for Treasury Shares was $4.0 million (2023), whereas its average is $3.3 million.
- Per our database at Business Quant, Intellia Therapeutics' Treasury Shares surged by 33487.91% in 2022 and then crashed by 379.49% in 2025.
- Intellia Therapeutics' Treasury Shares (Quarter) stood at $453026.0 in 2021, then soared by 328.54% to $1.9 million in 2022, then skyrocketed by 108.19% to $4.0 million in 2023, then soared by 37.26% to $5.5 million in 2024, then dropped by 5.48% to $5.2 million in 2025.
- Its Treasury Shares stands at $5.2 million for Q3 2025, versus $5.3 million for Q2 2025 and $5.5 million for Q1 2025.